ALISO VIEJO, Calif.--(BUSINESS WIRE)--AVANIR Pharmaceuticals (NASDAQ:AVNR) today announced that it has received a Staff Determination Letter from NASDAQ. The Staff Determination Letter notified the Company that the market value of its listed securities had been below the minimum $50 million market value required for inclusion on the NASDAQ Global Market for the previous 10 consecutive trading days. This minimum market value requirement is set forth in Marketplace Rule 4450(b)(1)(a).
